Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 2Glioma 2Colonic Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Ductal Adenocarcinoma 1Pain 1Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Magnetic Resonance Imaging 1Kidney Neoplasms 1Hypothyroidism 1Hyperphagia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Goiter 1Glioblastoma 1Emergencies 1Critical Illness 1Carcinoma, Renal Cell 1Cancer Pain 1Breast Neoplasms 1

Interventions

fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3Curcumin 3Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Methylprednisolone 2Filgrastim 2Cyclosporine 2Busulfan 2Biopsy 2Antilymphocyte Serum 2pyroxamide 1piperine 1liposomal amphotericin B 1isatuximab 1ibrutinib 1ferrous sulfate 1ferric gluconate 1aldesleukin 1Urination 1Topotecan 1Tissue Banks 1Therapeutics 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Sucrose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Monoclonal Gammopathy of Undetermined Significance × Glucose × Clear all
NCT03119883 2024-08-09

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Mayo Clinic

Phase NA Completed
35 enrolled
Plasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡